Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014
Giovanni Sotgiu(University of Sassari), Marieke van der Werf(European Centre for Disease Prevention and Control), Csaba Ködmön(European Centre for Disease Prevention and Control), Vahur Hollo(European Centre for Disease Prevention and Control), Nicolas Lefèbvre(Hôpital Civil, Strasbourg), Andrei Dadu(World Health Organization Regional Office for Europe), Dennis Falzon(World Health Organization)
Cited by 51
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure
|European Respiratory Journal|2021|397
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|321
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
|Clinical Infectious Diseases|2018|257